Fitzgerald Joseph Michael, EVP and Group President of Cardiology at Boston Scientific Corp ($BSX), sold about $31.5 million in company shares through 10 open market transactions over the past year. His most recent sale occurred on November 3, 2025. These sales rank him 469th among 11,678 insiders in our database by total value sold, above the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 34898 | $0.00 | 210,024.0000 | 1,494,500,000 | 19.93% | 0.00% |
| Feb. 16, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3960 | $0.00 | 0.0000 | 1,494,500,000 | 100.00% | 0.00% |
| Feb. 14, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4362 | $0.00 | 4,363.0000 | 1,494,500,000 | 49.99% | 0.00% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 2797 | $0.00 | 8,391.0000 | 1,494,500,000 | 25.00% | 0.00% |
| Feb. 16, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1806 | $74.73 | 219,141.0000 | 1,494,500,000 | 0.82% | 0.00% |
| Feb. 16, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3960 | $0.00 | 220,947.0000 | 1,494,500,000 | 1.82% | 0.00% |
| Feb. 14, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1990 | $74.73 | 216,987.0000 | 1,494,500,000 | 0.91% | 0.00% |
| Feb. 14, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4362 | $0.00 | 218,977.0000 | 1,494,500,000 | 2.03% | 0.00% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 33104 | $74.73 | 214,615.0000 | 1,494,500,000 | 13.36% | 0.00% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 2797 | $0.00 | 247,719.0000 | 1,494,500,000 | 1.14% | 0.00% |
| Feb. 13, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 34898 | $0.00 | 244,922.0000 | 1,494,500,000 | 16.62% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Restricted Stock Units | 18550 | $0.00 | 18,550.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Stock Option (Right to Buy) | 43776 | $0.00 | 43,776.0000 | 1,494,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3462 | $0.00 | 176,738.0000 | 1,494,500,000 | 2.00% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1612 | $74.12 | 175,126.0000 | 1,494,500,000 | 0.91% | 0.00% |
| Feb. 12, 2026 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3462 | $0.00 | 6,924.0000 | 1,494,500,000 | 33.33% | 0.00% |
| Nov. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 9610 | $0.00 | 173,276.0000 | 1,495,500,000 | 5.25% | 0.00% |
| Nov. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 690 | $0.00 | 182,886.0000 | 1,495,500,000 | 0.38% | 0.00% |
| Nov. 3, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 16928 | $99.76 | 213,048.0000 | 1,495,500,000 | 7.36% | 0.00% |
| Nov. 3, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 29472 | $99.14 | 183,576.0000 | 1,495,500,000 | 13.83% | 0.00% |
| Nov. 3, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,495,500,000 | 27.24% | 0.00% |
| Nov. 3, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 3600 | $100.75 | 229,976.0000 | 1,495,500,000 | 1.54% | 0.00% |
| Nov. 3, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 1,495,500,000 | 100.00% | 0.00% |
| Oct. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 41755 | $98.38 | 183,576.0000 | 1,495,500,000 | 18.53% | 0.00% |
| Oct. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 1,495,500,000 | 50.00% | 0.00% |
| Oct. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 8245 | $98.91 | 225,331.0000 | 1,495,500,000 | 3.53% | 0.00% |
| Oct. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,495,500,000 | 27.24% | 0.00% |
| Sept. 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 100,000.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Sept. 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 21830 | $104.89 | 211,746.0000 | 1,485,900,000 | 9.35% | 0.00% |
| Sept. 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 28170 | $105.85 | 183,576.0000 | 1,485,900,000 | 13.30% | 0.00% |
| Sept. 2, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,485,900,000 | 27.24% | 0.00% |
| Aug. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,485,900,000 | 27.24% | 0.00% |
| Aug. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 150,000.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 50000 | $104.63 | 183,576.0000 | 1,485,900,000 | 21.41% | 0.00% |
| July 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 50000 | $0.00 | 200,000.0000 | 1,485,900,000 | 20.00% | 0.00% |
| July 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 50000 | $106.97 | 183,576.0000 | 1,485,900,000 | 21.41% | 0.00% |
| July 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 50000 | $26.15 | 233,576.0000 | 1,485,900,000 | 27.24% | 0.00% |
| June 4, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 56372 | $102.88 | 183,576.0000 | 1,485,900,000 | 23.49% | 0.00% |
| June 4, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 56372 | $0.00 | 250,000.0000 | 1,485,900,000 | 18.40% | 0.00% |
| June 4, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 56372 | $26.15 | 239,948.0000 | 1,485,900,000 | 30.71% | 0.00% |
| Feb. 25, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 340 | $0.00 | 183,576.0000 | 1,485,900,000 | 0.18% | 0.00% |
| Feb. 24, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 340 | $0.00 | 183,576.0000 | 1,485,900,000 | 0.19% | 0.00% |
| Feb. 24, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 1700 | $0.00 | 183,916.0000 | 1,485,900,000 | 0.92% | 0.00% |
| Feb. 20, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 1000 | $0.00 | 185,276.0000 | 1,485,900,000 | 0.54% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4167 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4362 | $0.00 | 184,002.0000 | 1,485,900,000 | 2.43% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1990 | $106.11 | 182,012.0000 | 1,485,900,000 | 1.08% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3960 | $0.00 | 185,972.0000 | 1,485,900,000 | 2.18% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1806 | $106.11 | 184,166.0000 | 1,485,900,000 | 0.97% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4167 | $0.00 | 188,333.0000 | 1,485,900,000 | 2.26% | 0.00% |
| Feb. 17, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 2057 | $106.11 | 186,276.0000 | 1,485,900,000 | 1.09% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Restricted Stock Units | 11188 | $0.00 | 11,188.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 13, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Stock Option (Right to Buy) | 28789 | $0.00 | 28,789.0000 | 1,485,900,000 | 9999.99% | 0.00% |
| Feb. 14, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4362 | $0.00 | 8,725.0000 | 1,485,900,000 | 33.33% | 0.00% |
| Feb. 16, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3960 | $0.00 | 3,960.0000 | 1,485,900,000 | 50.00% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1579 | $105.77 | 179,640.0000 | 1,485,900,000 | 0.87% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3462 | $0.00 | 181,219.0000 | 1,485,900,000 | 1.95% | 0.00% |
| Feb. 12, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3462 | $0.00 | 10,386.0000 | 1,485,900,000 | 25.00% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 31680 | $0.00 | 192,204.0000 | 1,485,900,000 | 19.74% | 0.00% |
| Dec. 3, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | P | Common Stock | 50 | $90.29 | 153,062.0000 | 1,487,400,000 | 0.03% | 0.00% |
| Dec. 10, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 20 | $89.97 | 153,042.0000 | 1,487,400,000 | 0.01% | 0.00% |
| Feb. 11, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 14447 | $105.98 | 177,757.0000 | 1,485,900,000 | 7.52% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 6425 | $89.32 | 160,494.0000 | 1,485,900,000 | 3.85% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 13907 | $0.00 | 166,919.0000 | 1,485,900,000 | 9.09% | 0.00% |
| Jan. 1, 2025 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Performance Share Units | 13907 | $0.00 | 0.0000 | 1,485,900,000 | 100.00% | 0.00% |
| Nov. 25, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 1113 | $0.00 | 164,248.0000 | 1,487,400,000 | 0.67% | 0.00% |
| Nov. 26, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 11236 | $0.00 | 153,012.0000 | 1,487,400,000 | 6.84% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 57618 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 59021 | $0.00 | 0.0000 | 1,487,400,000 | 100.00% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 132527 | $85.00 | 165,361.0000 | 1,487,400,000 | 44.49% | 0.01% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 57618 | $24.98 | 297,888.0000 | 1,487,400,000 | 23.98% | 0.00% |
| Oct. 7, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 59021 | $17.26 | 240,270.0000 | 1,487,400,000 | 32.56% | 0.00% |
| Aug. 28, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 14132 | $80.00 | 181,249.0000 | 1,463,500,000 | 7.23% | 0.00% |
| May 13, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 2380 | $0.00 | 195,381.0000 | 1,463,500,000 | 1.20% | 0.00% |
| Feb. 20, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | I | Common Stock | 67974 | $66.22 | 197,761.0000 | 1,463,500,000 | 25.58% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4167 | $0.00 | 265,915.0000 | 1,463,500,000 | 1.59% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1806 | $65.82 | 261,748.0000 | 1,463,500,000 | 0.69% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3960 | $0.00 | 263,554.0000 | 1,463,500,000 | 1.53% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 3706 | $0.00 | 267,564.0000 | 1,463,500,000 | 1.40% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 2057 | $65.82 | 263,858.0000 | 1,463,500,000 | 0.77% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Deferred Stock Units | 3706 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Feb. 17, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4167 | $0.00 | 4,167.0000 | 1,463,500,000 | 50.00% | 0.00% |
| Feb. 16, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 3960 | $0.00 | 7,920.0000 | 1,463,500,000 | 33.33% | 0.00% |
| Feb. 18, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1829 | $65.82 | 265,735.0000 | 1,463,500,000 | 0.68% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 4362 | $0.00 | 261,584.0000 | 1,463,500,000 | 1.70% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Restricted Stock Units | 4362 | $0.00 | 13,087.0000 | 1,463,500,000 | 25.00% | 0.00% |
| Feb. 14, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 1990 | $65.95 | 259,594.0000 | 1,463,500,000 | 0.76% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 6000 | $0.00 | 257,222.0000 | 1,463,500,000 | 2.28% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | G | Common Stock | 550 | $0.00 | 257,222.0000 | 1,463,500,000 | 0.21% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Stock Option (Right to Buy) | 36509 | $0.00 | 36,509.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Restricted Stock Units | 13848 | $0.00 | 13,848.0000 | 1,463,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | A | Common Stock | 33332 | $0.00 | 279,122.0000 | 1,463,500,000 | 13.56% | 0.00% |
| Feb. 6, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 16450 | $0.00 | 262,672.0000 | 1,463,500,000 | 5.89% | 0.00% |
| Jan. 12, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 11660 | $60.00 | 245,820.0000 | 1,463,500,000 | 4.53% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | F | Common Stock | 10908 | $57.81 | 257,480.0000 | 1,463,500,000 | 4.06% | 0.00% |
| Dec. 29, 2023 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Stock Option (Right to Buy) | 58189 | $0.00 | 0.0000 | 1,439,700,000 | 100.00% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 21799 | $0.00 | 268,388.0000 | 1,463,500,000 | 8.84% | 0.00% |
| Dec. 29, 2023 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Common Stock | 58189 | $16.31 | 328,529.0000 | 1,439,700,000 | 21.52% | 0.00% |
| Jan. 1, 2024 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | M | Performance Share Units | 21799 | $0.00 | 0.0000 | 1,463,500,000 | 100.00% | 0.00% |
| Dec. 29, 2023 | BOSTON SCIENTIFIC CORP | $BSX | Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology | S | Common Stock | 81940 | $57.50 | 246,589.0000 | 1,439,700,000 | 24.94% | 0.01% |